"MacDonald Option" in Radiation Therapy
3D- Radiation versus IMRT versus Proton Therapy
Late cardiac side effects of Hodgkin's treatment
Considerations for Choosing Partial Breast Irradiation
CyberKnife for Bone Metastases
Does Obesity Affect Radiation Treatments?
Exercise during radiation Therapy
Hair Growth after Radiation to the Head
How Long After Radiation Can Tumor Keep Shrinking?
How Long Does Radiation Work?
IMRT for squamous cell carcinoma of the tonsil
IMRTTM: Patient Information and Frequently Asked Questions
Prevent Hair Loss with Tempol
PSA After Proton Therapy for Prostate Cancer
Radiation Colitis
Radiation Exposure to Others during I-131 Therapy
Radiation Pneumonitis
Radiation Safety Issues
Raditaion Therapy and Obesity
Skin care for radiation therapy patients
Sun Exposure After Radiation
Treatment for Esophagitis
Vaginal stenosis after radiation to the rectal/lower abdomen area
Whole brain radiation therapy for CNS lymphoma
Why not radiate 7 days a week?

Studies outline new options for the standard treatment of various lymphoma types

Dec 7, 2010 - Rituximab may be a better option than watchful waiting in some lymphoma patients, and a new treatment option appears effective for relapsed or refractory Hodgkin's lymphoma, according to two studies being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. Other research being presented will highlight new options for the standard treatment of advanced asymptomatic follicular lymphoma; mantle cell lymphoma; and early, unfavorable Hodgkin's disease.

I Wish You Knew

Understanding prostate cancer screening

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información